Mandatory Lab Tests Required Before Treatment of any Cancer
All Cancer treatments should be proceeded with a blood test to form a base line. The test should be repeated every month during active treatment to compare with base line. This step helps the patient to monitor the treatment’s benefits and improvement. On the other hand, it helps the treating physician to assess the treatment’s efficiency, effectiveness and what to do next.
- CEA (in general)
- Alpha Fetoprotein (in general)
- Tumor marker for the specific cancer or organ such as:
- CA 19-9 cancer of the gastrointestinal, pancreatic, and colorectal,
- CA 50 cancer of the gastrointestinal, biliary tract tumors, cholangiocarcinoma, oral cancer, pancreatic cancer, transitional cell carcinoma, non-small-cell lung cancer, benign extrahepatic jaundice, cirrhosis and cystic fibrosis,
- CA 72-4 cancer of the esophageal, gastric, and colorectal, plus (CEA),
- CA 125 ovarian carcinoma and breast cancer,
- CA 549 breast cancer sensitive in late stages and
- CA 15-3 Prostate cancer.
- Liver enzymes